Tracks pulmonary hypertension in people with lung cancer at Giessen
Records how often lung-related high blood pressure occurs in adults with lung cancer.
Plain-language title generated from the registry record
Registry title: Giessen Pulmonary Hypertension in Lung Cancer Registry
Key facts
- Where
- Giessen, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults with lung cancer treated at the University of Giessen Lung Cancer Center. Data come from normal care, with no extra treatment.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Lung cancer; no stage is named in the record
Read by machine on 12 November 2026.
Where in Germany
- University hospital GiessenGiessen, GermanyContact: Bastian Eul, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Giessen
- Trial code
- NCT04467333
- Record updated
- 1 April 2025
- Original description
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.Read full original descriptionShow less
Giessen Pulmonary Hypertension in Lung Cancer Registry
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Inclusion: Patient with lung cancer at the University of Giessen lung Cancer Center.
Exclusion: -.